| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Arpine Kocharyan initiates coverage on Xponential Fitness (NYSE:XPOF) with a Neutral rating and announces Price ...
Raymond James analyst Joseph Altobello maintains Xponential Fitness (NYSE:XPOF) with a Strong Buy and lowers the price targe...
Xponential Fitness (NYSE:XPOF) lowers FY2025 sales outlook from $315.00 million-$325.00 million to $300.00 million-$310.00 mill...
Xponential Fitness (NYSE:XPOF) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.2...